Torben Moos
Torben Moos
Verified email at hst.aau.dk
Title
Cited by
Cited by
Year
A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy
KB Johnsen, JM Gudbergsson, MN Skov, L Pilgaard, T Moos, M Duroux
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 75-87, 2014
4542014
Proteasomal inhibition by α-synuclein filaments and oligomers
E Lindersson, R Beedholm, P Højrup, T Moos, WP Gai, KB Hendil, ...
Journal of Biological Chemistry 279 (13), 12924-12934, 2004
3882004
The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease
B Mirza, H Hadberg, P Thomsen, T Moos
Neuroscience 95 (2), 425-432, 1999
3581999
Iron trafficking inside the brain
T Moos, TR Nielsen, T Skjørringe, EH Morgan
Journal of neurochemistry 103 (5), 1730-1740, 2007
3572007
Transferrin and transferrin receptor function in brain barrier systems
T Moos, EH Morgan
Cellular and molecular neurobiology 20 (1), 77-95, 2000
3452000
The metabolism of neuronal iron and its pathogenic role in neurological disease
T Moos, EH MORGAN
Annals of the New York Academy of Sciences 1012 (1), 14-26, 2004
2752004
Strongly compromised inflammatory response to brain injury in interleukin‐6‐deficient mice
M Penkowa, T Moos, J Carrasco, H Hadberg, A Molinero, H Bluethmann, ...
Glia 25 (4), 343-357, 1999
2121999
CNS wound healing is severely depressed in metallothionein I-and II-deficient mice
M Penkowa, J Carrasco, M Giralt, T Moos, J Hidalgo
Journal of neuroscience 19 (7), 2535-2545, 1999
1691999
Targeting Anti—Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion
S Gosk, C Vermehren, G Storm, T Moos
Journal of Cerebral Blood Flow & Metabolism 24 (11), 1193-1204, 2004
1682004
Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system
T Moos
Journal of Comparative Neurology 375 (4), 675-692, 1996
1651996
Restricted transport of anti‐transferrin receptor antibody (OX26) through the blood–brain barrier in the rat
T Moos, EH Morgan
Journal of neurochemistry 79 (1), 119-129, 2001
1632001
p25α stimulates α-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies
E Lindersson, D Lundvig, C Petersen, P Madsen, JR Nyengaard, ...
Journal of Biological Chemistry 280 (7), 5703-5715, 2005
1602005
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
S Gosk, T Moos, C Gottstein, G Bendas
Biochimica et Biophysica Acta (BBA)-Biomembranes 1778 (4), 854-863, 2008
1482008
CXCL10 is the key ligand for CXCR3 on CD8+ effector T cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system
JE Christensen, C de Lemos, T Moos, JP Christensen, AR Thomsen
The Journal of Immunology 176 (7), 4235-4243, 2006
1432006
The vascular basement membrane in the healthy and pathological brain
MS Thomsen, LJ Routhe, T Moos
Journal of Cerebral Blood Flow & Metabolism 37 (10), 3300-3317, 2017
1332017
Brain iron homeostasis.
T Moos
Danish medical bulletin 49 (4), 279, 2002
1302002
Evidence for low molecular weight, non‐transferrin‐bound iron in rat brain and cerebrospinal fluid
T Moos, EH Morgan
Journal of neuroscience research 54 (4), 486-494, 1998
1171998
The significance of the mutated divalent metal transporter (DMT1) on iron transport into the Belgrade rat brain
T Moos, EH Morgan
Journal of neurochemistry 88 (1), 233-245, 2004
1092004
Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration
HH Andersen, KB Johnsen, T Moos
Cellular and molecular life sciences 71 (9), 1607-1622, 2014
982014
Efficient T-cell surveillance of the CNS requires expression of the CXC chemokine receptor 3
JE Christensen, A Nansen, T Moos, B Lu, C Gerard, JP Christensen, ...
Journal of Neuroscience 24 (20), 4849-4858, 2004
932004
The system can't perform the operation now. Try again later.
Articles 1–20